Evogene Earnings Estimates, EPS & Revenue | NASDAQ:EVGN

Comments

Evogene Ltd Earnings Estimates

EVGNNASDAQ

Trade with Public

$0.7910

-0.0631-7.39%

Last update: Apr 16, 12:32 PM

Overview NewsEarningsAnalyst Ratings Short Interest Stock Report

Evogene Earnings Estimates, EPS & Revenue | NASDAQ:EVGN

Evogene (EVGN) is scheduled to report Q1 earnings on May 20, 2026. Analysts estimate EPS of $-0.27 and quarterly revenue of $350.00K.

In the most recent quarter (Q4), Evogene reported EPS of $-0.61, missing estimates of $-0.26 by 1.35%. Revenue came in at $314.00K, exceeding the estimate of $275.00K by 0.14%.

Over the last 4 quarters, Evogene has averaged an EPS surprise of 0.51% and a revenue surprise of 0.29%.

Earnings Date

May 20

EPS Estimate

$-0.270

Quarterly Revenue Estimate

$350.00K

Annual Revenue
(as of Dec 31)

$3.85M

Evogene Earnings History

Analyze the earnings history of Evogene using advanced sorting and filters.

Loading calendar...

Evogene (EVGN) Earnings Per Share

The chart below shows Evogene's reported EPS compared to analyst estimates over recent quarters.

Evogene (EVGN) Revenue

The chart below shows Evogene's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Evogene (NASDAQ:EVGN) reporting earnings?

Evogene (EVGN) is scheduled to report earnings on May 20, 2026. The last reported earnings were for reported on March 5, 2026 for Q4.

What were the latest earnings per share (EPS) for Evogene (NASDAQ:EVGN)?

The Actual EPS was $-0.61, which missed the estimate of $-0.26.

What were Evogene’s (NASDAQ:EVGN) revenues?

The Actual Revenue was $314.00K, which beat the estimate of $275.00K.

People Also Watch

Acurx Pharmaceuticals Inc

NASDAQ:ACXP

$2.58

-17.42%

Quoin Pharmaceuticals Ltd

Bolt Biotherapeutics Inc

NASDAQ:BOLT

$4.81

-2.04%

AlphaTON Capital Corp

TransCode Therapeutics Inc

NASDAQ:RNAZ

$8.99

0.90%

Evogene Earnings Estimates, EPS & Revenue | NASDAQ:EVGN

Evogene (EVGN) is scheduled to report Q1 earnings on May 20, 2026. Analysts estimate EPS of $-0.27 and quarterly revenue of $350.00K.

In the most recent quarter (Q4), Evogene reported EPS of $-0.61, missing estimates of $-0.26 by 1.35%. Revenue came in at $314.00K, exceeding the estimate of $275.00K by 0.14%.

Over the last 4 quarters, Evogene has averaged an EPS surprise of 0.51% and a revenue surprise of 0.29%.

Earnings Date

May 20

EPS Estimate

$-0.270

Quarterly Revenue Estimate

$350.00K

Annual Revenue
(as of Dec 31)

$3.85M